美國食品及藥物管理局（FDA）頒發「對有關嬰兒配方食品的健康資訊忠告」
即時發佈﹕2008 年 9 月 11 日
聯絡﹕Judy Leon, 電話﹕301-827-3314 或 301-696-8921, 電子郵件﹕judy.leon@fda.hhs.gov

為了應對有關中國制造的受污染嬰兒配方奶粉之報道， 今天美國食品及藥物管理局 (FDA) 頒發了健康資訊忠告。 本忠告旨在使美國大眾確信，在符合要求在美國銷售嬰兒配方食品的公司所制造的嬰兒配方食品中未發現任何受污染之威脅。 雖然尚無中國的嬰兒配方食品制造商符合在美國銷售嬰兒配方食品之要求，美國食品及藥物管理局（ FDA）官員正在調查中國制造的嬰兒配方食品是否在為亞裔社區服務的特種市場內銷售。

美國食品及藥物管理局（ FDA） 建議看護人員勿用中國制造的嬰兒配方食品喂養嬰兒。取而代之的應該是如下所述之合適的美國制造嬰兒配方食品。家長倘若對自己嬰兒的健康懷有疑問，或者注意到自己嬰兒的健康狀況發生變化，應立即聯絡健康護理專業人士。美國食品及藥物管理局（ FDA）在獲悉有關受污染食品的報告後立即展開調查，並收到來自為美國市場生產嬰兒配方食品的公司之資訊，明確表示他們不從中國進口嬰兒配方食品或原料。下列制造商符合美國食品及藥物管理局（ FDA）對在美國經銷嬰兒配方奶粉之規定要求﹕Abbott Nutritionals, Mead Johnson Nutritionals, Nestle USA, PBM Nutritionals, 與Solus Products LLC。另外有一家英國利物浦的SHS/Nutricia 制造商。該公司制造的以氨基酸為基礎的萃取物嬰兒配方食品不含牛奶衍生成分。

我們要求各州政府官員與本管理局一起，協助去除商店貨架上發現的任何中國制造嬰兒配方食品，並且警告亞裔社區成員避免使用中國制造的嬰兒配方食品。

 
據報道，在中國有些食用中國制造的嬰兒配方食品的嬰兒患腎結石，這種病情一般在嬰兒身上很少出現。中國制造的嬰兒配方食品可能含三聚氰胺。 三聚氰胺會偽造牛奶內的蛋白質含量，從而導致諸如這些中國嬰兒身上發現的腎結石病癥。

FDA News

FOR IMMEDIATE RELEASE
September 12, 2008

Media Inquiries:
Judy Leon, 301-827-3314 or 301-696-8921
Consumer Inquiries:
888-INFO-FDA

FDA Issues Health Information Advisory on Infant Formula

In response to reports of contaminated milk-based infant formula manufactured in China, the U.S. Food and Drug Administration (FDA) today is issuing a Health Information Advisory. This is to assure the American public that there is no known threat of contamination in infant formula manufactured by companies that have met the requirements to sell infant formula in the United States. Although no Chinese manufacturers of infant formula have fulfilled the requirements to sell infant formula in the United States, FDA officials are investigating whether or not infant formula manufactured in China is being sold in specialty markets which serve the Asian community.

The FDA is advising caregivers not to feed infant formula manufactured in China to infants. This should be replaced with an appropriate infant formula manufactured in the United States as mentioned below. Individuals should contact their health care professional if they have questions regarding their infant’s health or if they note changes in their infant’s health status.

The FDA began investigating the reports of contamination immediately and received information from the companies who manufacture infant formula for the American market that they are not importing infant formula or source materials from China. The following manufacturers have met the necessary FDA requirements for marketing milk-based infant formulas in the United States: Abbott Nutritionals, Mead Johnson Nutritionals, Nestle USA, PBM Nutritionals, and Solus Products LLC. Also, one manufacturer, SHS/Nutricia, Liverpool, England, markets an amino acid based exempt infant formula that does not contain any milk-derived ingredients.

We are asking state officials to work with the Agency to assist with the removal of any Chinese infant formula found on store shelves, and to warn members of the Asian community to avoid using Chinese manufactured infant formula.

It has been reported that a number of infants in China who have consumed Chinese manufactured infant formula are suffering from kidney stones, a condition which is rare in infants.  The Chinese manufactured infant formula may be contaminated with melamine. Melamine artificially increases the protein profile of milk and can causes kidney diseases such as those seen in these Chinese infants.

FDA requires that all infant formula manufacturers register with the Agency and adhere to specific labeling and nutritional requirements.  All properly registered infant formula manufacturers marketing infant formula in the United States undergo an annual inspection of their production facilities.

英文原文：http://www.fda.gov/bbs/topics/NEWS/2008/NEW01883.html 

中文原文：http://www.fda.gov/bbs/topics/NEWS/2008/NEW01883_Traditional%20Chinese.pdf